Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer’s disease
Alzheimer’s disease is a neurodegenerative disorder mainly characterized by β-amyloid deposit and tau hyperphosphorylation with no curative treatments. Curcumin (Cur) has been proved to have potential use in Alzheimer’s disease with its anti-amyloid, anti-inflammatory, and anti-oxidant properties, e...
Main Authors: | Shengnuo Fan, Yuqiu Zheng, Xuan Liu, Wenli Fang, Xiaoyu Chen, Wang Liao, Xiuna Jing, Ming Lei, Enxiang Tao, Qiulan Ma, Xingmei Zhang, Rui Guo, Jun Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-01-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10717544.2018.1461955 |
Similar Items
-
Investigating a Curcumin-Loaded PLGA-PEG-PLGA Thermo-Sensitive Hydrogel for the Prevention of Alzheimer’s Disease
by: Yi-Wen Lin, et al.
Published: (2022-04-01) -
A hydrophobic peptide fraction that enhances the water dispersibility of curcumin
by: Risa Yamashita, et al.
Published: (2016-10-01) -
WHAT’S IN CURCUMIN’S MIND? THE POTENTIAL ROLE OF CURCUMINOIDS IN THE TREATMENT OF ALZHEIMER’S DISEASE
by: Paola Marzullo
Published: (2021-03-01) -
Evaluation of polymeric PLGA nanoparticles conjugated to curcumin for use in aPDT
by: Renata Celi Carvalho de Souza Pietra, et al.
Published: (2017-07-01) -
Trastuzumab- and Fab′ fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo
by: Duan D, et al.
Published: (2018-03-01)